2021-01-05,CORRECTION -- Myovant Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
2021-01-05,"The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data"
2021-01-05,Myovant Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
2021-01-05,Myovant Sciences Announces U.S. Availability of ORGOVYX for the Treatment of Advanced Prostate Cancer
2021-01-04,Myovant Sciences Appoints Industry Veteran David Marek as Chief Executive Officer
2020-12-30,"Biotech Stock Roundup: REGN Provides COVID-19 Updates, MYOV Partners With PFE & More"
2020-12-30,Myovant Shares Soar on $4.2 Billion Development Collaboration with Pfizer; Target Price $42
2020-12-29,Myovant (MYOV) Up on Collaboration With Pfizer for Relugolix
2020-12-29,"Company News for Dec 29, 2020"
2020-12-28,10 Biggest Stock Gainers and Losers Today
2020-12-28,Myovant Sciences Hits Record High On Development Deal With Pfizer
2020-12-28,"5 Top Stock Gainers for Monday: Myovant Sciences, Yelp"
2020-12-28,Myovant shares soar 27% on news of Pfizer prostate cancer drug collaboration worth up to $4.2 billion
2020-12-28,Why Myovant Sciences Stock Is Soaring Today
2020-12-28,Myovant Up on $4.2B Pfizer Pact to Develop Prostate-Cancer Drug
2020-12-28,UPDATE: Myovant shares soar 20% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion
2020-12-28,Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Womens Health
2020-12-24,3 Stocks J.P. Morgan Says Are Ready to Rip Higher
2020-12-18,"Myovant Sciences Announces FDA Approval of ORGOVYX (relugolix), the First and Only Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer"
2020-12-16,Is MYOV A Good Stock To Buy Now?
2020-12-16,Is the Options Market Predicting a Spike in Myovant Sciences (MYOV) Stock?
2020-12-16,Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
2020-11-23,Myovant Sciences to Present at Upcoming December Investor Conferences
2020-11-18,Breakeven On The Horizon For Myovant Sciences Ltd. (NYSE:MYOV)
2020-11-17,Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
2020-11-12,Recap: Myovant Sciences Q2 Earnings
2020-11-12,Myovant Sciences Announces Corporate Updates and Financial Results for Second Quarter Fiscal Year 2020
2020-11-12,Myovant Sciences Ltd. to Host Earnings Call
2020-11-02,"Myovant Sciences to Host Second Fiscal Quarter 2020 Earnings Conference Call at 8:30 a.m. Eastern Time on November 12, 2020"
2020-10-21,Myovant Sciences Presents Additional Data on Relugolix Combination Therapy from Studies in Endometriosis and Uterine Fibroids
2020-10-14,"Myovant Sciences Appoints Ryan Crowe as Vice President, Investor Relations"
2020-10-03,How to Catch a Falling Knife
2020-09-29,Myovant Sciences Stock Crashes On Poor Trial Data For Prostate Cancer Treatment
2020-09-29,Why Myovant's Stock Is Trading Lower Today
2020-09-29,"SHAREHOLDER ALERT: Investigation of Myovant Announced by Holzer & Holzer, LLC"
2020-09-29,Myovant Sciences Announces Results of Additional Secondary Endpoint of Castration Resistance-Free Survival from Phase 3 HERO Study of Relugolix in Advanced Prostate Cancer
2020-09-25,Is the Options Market Predicting a Spike in Myovant Sciences (MYOV) Stock?
2020-09-23,Myovant Sciences Launches Forward for Health Equity Grant Program to Improve Healthcare Access in Prostate Cancer and Uterine Fibroids
2020-09-14,Myovant Sciences Presents Additional Data on Bone Mineral Density in Women with Uterine Fibroids from Phase 3 LIBERTY Program and from Prospective Observational Study
2020-08-20,Is Myovant Sciences' (NYSE:MYOV) 152% Share Price Increase Well Justified?
2020-08-17,Myovant Sciences Announces FDA Acceptance of New Drug Application for Once-Daily Relugolix Combination Tablet for Uterine Fibroids
2020-08-11,Myovant Sciences Announces Corporate Updates and Financial Results for First Quarter Fiscal Year 2020
2020-08-05,Myovant Sciences Announces Further Financing Support from Sumitomo Dainippon Pharma and Commercial Collaboration with Sunovion Pharmaceuticals
2020-07-06,Myovant Sciences Presents Additional Data on Relugolix Combination Therapy from Phase 3 LIBERTY Studies in Women with Uterine Fibroids and from Ovulation Inhibition Study
2020-07-05,Myovant Sciences Ltd. (MYOV): Hedge Fund Sentiment Unchanged
2020-07-01,Goldman Sachs: Theres an Opportunity Brewing in These 3 Stocks
2020-06-30,"BlackDoctor.org, Evidation Health, Movember, and Myovant Sciences Launch Forward Momentum Coalition to Increase Diversity in Research and Develop New Digital Resources for Men with Prostate Cancer"
2020-06-24,"Myovant's Endometriosis Pain Drug Meets Goal in Study, Stock Up"
2020-06-24,"Company News for Jun 24, 2020"
2020-06-23,Myovant's stock gains on promising endometriosis drug trial
2020-06-23,Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis
2020-06-22,"Sumitovant Biopharma Announces Priority Review and FDA Acceptance of Myovant Sciences New Drug Application for Once-Daily, Oral Relugolix for Advanced Prostate Cancer"
2020-06-22,"Myovant Sciences to Host Webcast and Conference Call at 8:30 am Eastern Time Tuesday, June 23 to Discuss Results from Phase 3 SPIRIT 1 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis"
2020-06-22,"Myovant Sciences Announces Priority Review and FDA Acceptance of New Drug Application for Once-Daily, Oral Relugolix for Advanced Prostate Cancer"
2020-06-02,Myovant Eyes Relugolix Combo Approval for Uterine Fibroids
2020-06-02,Do Options Traders Know Something About Myovant (MYOV) Stock We Don't?
2020-06-02,"Company News for June 2, 2020"
2020-06-01,Sumitovant Biopharma Announces Myovant Sciences' Submission of New Drug Application (NDA) to the FDA for Once-Daily Relugolix Combination Tablet for the Treatment of Women with Uterine Fibroids
2020-06-01,Myovant Sciences Submits New Drug Application (NDA) to the FDA for Once-Daily Relugolix Combination Tablet for the Treatment of Women with Uterine Fibroids
2020-05-29,"Sumitovant Biopharma Announces Myovant Sciences' Additional Positive Efficacy and Cardiovascular Safety Data from Phase 3 HERO Study of Once-Daily, Oral Relugolix in Advanced Prostate Cancer and Publication in the New England Journal of Medicine"
2020-05-29,"Myovant Sciences Announces Additional Positive Efficacy and Cardiovascular Safety Data from Phase 3 HERO Study of Once-Daily, Oral Relugolix in Advanced Prostate Cancer and Publication in the New England Journal of Medicine"
2020-05-18,"Myovant Sciences Provides Recent Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2020"
2020-05-14,Myovant Sciences to Present New Data on Relugolix in Prostate Cancer at American Society of Clinical Oncology (ASCO) 2020 Annual Meeting
2020-05-06,Were Smart Money Traders Right About Myovant Sciences Ltd. (MYOV)?
2020-05-02,"Notable Insider Buys This Past Week: Immunomedics, Simply Good Foods And More"
2020-04-27,Myovant Sciences Announces Publication of Abstracts Detailing Additional Efficacy and Safety Findings from Phase 3 LIBERTY Studies in Uterine Fibroids in Obstetrics & Gynecology
2020-04-26,"Insiders Roundup: Procter & Gamble, Uber"
2020-04-22,"The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership"
2020-04-22,Myovant Eyes Relugolix Approval for Advanced Prostate Cancer
2020-04-22,Myovant Sciences Announces Positive Results from Phase 3 SPIRIT 2 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis and from Ovulation Inhibition Study
2020-04-21,"Against backdrop of shelter-in-place, Peninsula biotech asks FDA to approve prostate cancer drug"
2020-04-21,"Myovant Sciences to Host Webcast and Conference Call at 8:30 a.m. Eastern Time Wednesday, April 22 to Discuss Results from Phase 3 SPIRIT 2 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis and from Ovulation Inhibition Study"
2020-04-21,"Myovant Sciences Submits New Drug Application (NDA) to the FDA for Once-Daily, Oral Relugolix for the Treatment of Men with Advanced Prostate Cancer"
2020-04-15,Myovant Sciences (MYOV) Jumps: Stock Rises 8.3%
2020-04-14,Myovant Sciences and HealthyWomen Launch Storytelling Initiative to Elevate Conversations About Menstrual Health
2020-04-09,Why Myovant Sciences (MYOV) Stock Might be a Great Pick
2020-03-31,Myovant Sciences and Gedeon Richter Enter into Exclusive License Agreement to Commercialize Relugolix Combination Tablet for Uterine Fibroids and Endometriosis in Certain Territories Outside the U.S.
2020-03-10,Myovant Sciences Announces Cancellation of Presentation and Webcast at the Barclays Global Healthcare Conference 2020
2020-03-09,Myovant Sciences Submits Marketing Authorization Application to the European Medicines Agency for Relugolix Combination Tablet for the Treatment of Women with Uterine Fibroids
2020-02-25,Myovant Sciences to Present at Upcoming March Investor Conferences
2020-02-21,Is the Options Market Predicting a Spike in Myovant (MYOV) Stock?
2020-02-10,"Myovant Sciences Provides Recent Corporate Updates and Reports Financial Results for Third Fiscal Quarter Ended December 31, 2019"
2020-02-10,Myovant Sciences Announces 88% One-Year Response Rate in Positive Phase 3 LIBERTY Extension Study of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
2020-02-03,Former Genentech exec looks to replicate that 'magical time' with new biotech model
2020-01-22,Top Picks 2020- Myovant Sciences Ltd. MYOV
2020-01-06,Myovant Sciences to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-12-30,"Myovant Sciences Announces Closing of $400 Million Loan Facility, Repayment of Debt, Board of Director Transitions, and Executive Promotions"
2019-12-13,Hedge Funds Had Impeccable Timing Buying Myovant Sciences Ltd. (MYOV)
2019-12-06,Should You Be Concerned About Myovant Sciences Ltd.'s (NYSE:MYOV) Historical Volatility?
2019-11-29,Biotech Tops in November: Best ETFs & Stocks
2019-11-29,Is the Options Market Predicting a Spike in Myovant (MYOV) Stock?
2019-11-26,Myovant (MYOV) Catches Eye: Stock Jumps 6.7%
2019-11-25,"Myovant Sciences to Present at the Evercore ISI 2nd Annual HealthCONx Conference on December 3, 2019"
2019-11-22,Fighting FOMO And Finding Profit In Consistency
2019-11-20,"Biotech Stock Roundup: MYOV & KRTX Surge, Pipeline Updates From VRTX, CELG & More"
2019-11-20,Myovant Up on Successful Completion of Prostate Cancer Study
2019-11-19,"With prostate cancer trial done, Peninsula drug maker will ask for FDA approval early next year"
2019-11-19,UPDATE: Myovant stock rockets 79% premarket on news of positive trial of prostate cancer treatment
2019-11-19,Myovant's Stock Soars After Relugolix Aces Late-Stage Study For Prostate Cancer
2019-11-19,"The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout"
